9Schiller JH, Hamngton D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med, 2002, 346:92-98.
10Shepherd FA. Chemotherapy for non-small cell lung cancer: have wereached a new plateau? Semin Oncol, 1999, 26 (1 Suppl 4) : 3-11.
6Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of doctaxel versus best supportive care in patients with non- small-cell lung cancer previously treated with platinum-based chemotherapy[ J]. J Clin Oncol, 2000, 18(10) : 2095-2103.
7Fossella FV, DeVore R, Kerr RN, et al. Randomized phasem trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens: the TAX 320 Non- Small-Cell Lung Cancer Study Group[ J]. J Clin Oncol, 2000, 18 (12) : 2354-2362.
8Alberto ME, Lucas MF, Pavelka M, et al. The second generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism [ J ]. J Phys Chem B, 2009, 113 (43) : 14473-14479.